Triomics is building the agentic AI layer for oncology EHRs. Cancer hospitals spend billions on highly trained staff manually reading unstructured patient records - pathology reports, clinical notes, genomic panels - to power workflows like trial matching, registry curation, visit prep, and quality reporting. We replace that manual work with task-driven AI agents that sit inside the EMR and process records at scale, in real time.

Our platform is trusted by leading cancer centers including Memorial Sloan Kettering, Mount Sinai, and Yale Cancer Center. We have grown 10x in the last year and process millions of oncology medical documents monthly.

Our investors include Battery Ventures, Lightspeed, General Catalyst, Nexus Venture Partners, and Y Combinator.